Previous literature has shown mixed results regarding the association between blood pressure levels and brain volume reduction. The objectives of this study were to determine whether high blood pressure levels were associated with focal brain volume reduction and whether high blood pressure-related focal brain volume reduction was associated with a decline in executive function performance. On the basis of a cross-sectional design, 24-hour ambulatory blood pressure measurements, as well as brain morphology from 3-dimensional magnetic resonance images, were assessed among 183 participants (mean, 65±0.6 years; 62.4% women). Average levels of systolic and diastolic blood pressures, as well as dip, pulse pressure, and mean arterial blood pressure, were used as outcomes. Cortical gray and white matter volumes were determined by automatic calculation using Statistical Parametric Mapping segmentation. Folstein's Mini-Mental State Examination, digit span, part B of Trail Making, and Stroop tests were used to assess executive function performance. Sex, use of antihypertensive drugs, duration of hypertension, leukoaraiosis, body mass index, education level, and total brain matter volume were used as potential confounders. A significant blood pressure-related decrease in gray matter volume of the left supplementary motor areas (Brodmann area 6) and of the left superior and middle frontal gyrus (Brodmann area 8) was shown. No significant decrease was found with white matter volume. Blood pressurerelated decreases in gray matter volume were significantly associated with a decline in executive function performance. The association of high blood pressure with brain volume reduction may in part explain blood pressure-related cognitive decline leading to dementia. (Hypertension. 2012;60:1324-1331.) • Online Data Supplement
S ince the first report by Hatazawa et al 1 in 1984, a growing number of epidemiological studies have shown that high blood pressure (BP) levels are associated with lower volume of regional brain tissue. [1] [2] [3] [4] [5] [6] [7] [8] [9] Most of these previous studies used occasional clinical BP measurements for BP assessment. 1, [3] [4] [5] [6] Compared with these few BP readings, ambulatory 24-hour BP monitoring provides numerous readings throughout the day and night. 9, 10 Thus, 24-hour BP gives a more sensitive measure of vessel-targeted end-organ damage, such as that observed in the brain. 2, 9 Among the 4 previous studies that used 24 -hour BP monitoring to examine the association between BP levels and brain volume reduction, 2, 8, 9, 11 1 study found no association between mean values of all BP measures and focal volume reduction, 11 where 3 reported a significant association of focal brain volume reduction with high mean value of systolic BP (SBP) and with high SBP sleep variability. 2, 8, 9 No association was shown with diastolic BP (DBP). 2, 8, 11 These mixed results underscore the need for additional information to improve our knowledge of the association between BP levels and brain volume reduction.
The association between high BP levels and low cognitive performance is now well established. [12] [13] [14] Executive function (EF) performance seems to be one of the domains most sensitive to high BP levels. 6, [12] [13] [14] EFs are heterogeneous cognitive functions. 15 According to the model by Miyake et al, 15 EF may be divided into 3 main separate executive subdomains (ESDs): mental shifting, information updating, and cognitive inhibition. Little is known about the association between these specific ESDs and BP-related decreases in gray and white matter volumes. 6 Previous studies of brain volume reduction have mainly used magnetic resonance imaging. [1] [2] [3] [4] [5] [6] [7] [8] 11 In the last 10 years, new analysis methods for identifying and segmenting brain structures and functions have been developed. Despite its limitations attributable to the high variability of brain anatomy, the voxel-based morphometry (VBM) method has proved its value in identifying regional changes in brain tissue volume. 16 We had the opportunity to examine the association between 24-hour BP measurements and gray and white matter volumes in a large representative community survey of older adults, the PROgnostic indicator OF cardiovascular and cerebrovascular events (PROOF) study. 17 We reported previously that high mean BP levels were associated with a decline in memory performance related to attention disorders, involving the frontal lobe among the participants of the PROOF study. 13 Thus, we hypothesized that high mean BP levels could be associated with focal frontal lobe volume reduction and that high BP-related focal frontal volume reduction could be associated with a decline in EF performance. The purposes of this crosssectional study were to determine at the baseline assessment of the PROOF study whether high BP levels were associated with focal brain volume reduction and whether any significant high BP-related focal brain volume reduction was associated with a decline in ESDs performance.
Methods

Brain Imaging and Neuropsychological Assessment
A total of 183 participants from the PROOF study 17 were included in the current study (see online-only Data Supplement for description of participant's selection). All participants had 3D T 1 -weighted magnetic resonance imaging at 1.0 Tesla to measure gray matter and white matter volumes, and fluid-attenuated inversion recovery imaging to rate leukoaraiosis using the Fazekas standardized scale (see online-only Data Supplement). VBM was performed with Statistical Parametric Mapping version 8 to classify voxels into gray and white matter (see online-only Data supplement material for description of image analysis). Neuropsychological tests were used to probe several aspects of cognitive function at baseline before BP measurements (see online-only Data supplement).
BP Measurement
Noninvasive and validated arterial BP was assessed by ambulatory 24-hour BP monitoring using the auscultatory method (Diasys Integra, Novacor, Rueil-Malmaison, France) on a weekday, starting early in the morning. 18 Measurements were taken from the nondominant arm, every 15 minutes during the day and every 30 minutes at night. Patients were instructed to adhere to their normal daily activities and regular sleeping hours. In addition, clinical SBP and DBP measures were performed. BP was measured twice by a physician with a mercury sphygmomanometer after the patient had been lying down for 15 minutes. BP was measured in the lying position for convenience at the end of a 15- 19, 20 Covariates Sex, use of antihypertensive drugs, leukoaraiosis (Fazekas score), 21 body mass index, cardiovascular risk factors (ie, use of antihypertensive drugs, type 2 diabetes mellitus, duration of hypertension, smoking, alcohol use, and hypercholesterolemia), education level, and total brain matter volume were examined as potential confounders in data analysis. Antihypertensive drugs were defined by the use of ≥1 of the following drug therapies: renin-angiotensin inhibitor agents, β-blocking agents, diuretics, calcium channel blockers, and central antihypertensive agents. The use of antihypertensive drugs was combined into a single Yes versus No category. Type 2 diabetes mellitus was considered to be present in case of the use of oral antidiabetic drugs. The smoking status was defined as current or former smoker versus nonsmoker. Alcohol consumption was combined into the 2 following categories, regular versus nonregular consumer of beer, wine, or spirits. Hypercholesterolemia was defined as a total cholesterol level >6.5 mmol/L or use of lipid-lowering drugs or both. Education level was assessed with the number of years at school categorized in 4 levels (level 1≤5 years, level 2=6-8 years, level 3=9-11, and level 4≥12). Participants were separated into 2 groups based on the presence (Fazekas scale score ≥2) or absence (Fazekas scale score <2) of significant leukoaraiosis. 21
Data Analyses
Participants' baseline characteristics were summarized using means and SDs or frequencies and percentages, as appropriate. First, comparisons between participants included in this study and the other participants of the PROOF study were performed using the independent samples t test or χ 2 test, as appropriate. Second, the association between mean BP measures and local gray or white matter volumes was examined by using the Statistical Parametric Mapping multiple linear regression models. Because a frontal gray matter association was hypothesized, a frontal mask was created with the WFUPick Atlas toolbox version 3.0.3. 22 White matter voxelwise VBM analysis was performed on the whole brain, as well as on frontal lobes. Each BP measure (ie, 24-hour SBP and DBP, awake SBP and DBP, sleep SBP and DBP, Dip, pulse pressure, and MAP) was used as an independent variable and analyzed separately. All models were adjusted for sex, duration of hypertension, use of antihypertensive drugs, body mass index, binary leukoaraiosis level, and total brain matter volume. Statistical threshold for VBM analyses was set at P<0.001 at the voxel level uncorrected for multiple comparisons, and an extent threshold on cluster size was chosen at 200 voxels to have a P value on the extent threshold close to 0.05. Moreover, a statistical threshold of P<0.05 uncorrected for multiple comparisons was set at the cluster level. Third, in regions showing a significant association between high BP and decrease in gray matter volume, multiple linear regression models were performed to examine the association between relevant high BP-related change in cluster size (dependent variable) and ESDs performance (independent variables) adjusted for sex and education level. In each analysis, gray matter volume was calculated using only pixels that were significantly associated with the specific BP measure being examined. P<0.05 was considered statistically significant. These statistics were performed using Stata (release 12.0, Stata Corp, College Station, TX).
Results
There was no significant difference between the participants included in the current study and the other participants of the PROOF study with regard to the clinical characteristics (Table 1) . Table 2 shows the prevalence of leukoaraiosis stratified by class according to the Fazekas scale in the participants separated into 2 groups based on use of antihypertensive drugs (ie, renin-angiotensin inhibitor agents, β-blocking agents, diuretics, calcium channel blockers, and central antihypertensive agents). No significant difference was shown between participants using antihypertensive drugs and those who did not.
As reported in Table 3 , a significant decrease in gray matter volume of the left supplementary motor area (Brodmann area BA6) was associated with an increase in the mean value of 24-hour SBP (P=0.003; Figure 1 ), 24-hour DBP (P=0.035), awake SBP (P=0.004), sleep SBP (P=0.015), and MAP (P=0.003). A significant decrease in gray matter volume of the left superior frontal gyrus wass ‡ ‡BP was measured twice by a physician with a mercury sphygmomanometer after the patient had been lying down for 15 minutes, and the clinical value retained was the mean of the 2 consecutive measurements. associated with an increase in mean value of 24-hour SBP (P=0.023), awake SBP (P=0.018), and MAP (P=0.008; Figure 2 ). In addition, high-sleep SBP (P=0.013; Figure 3 ) and sleep DBP (P=0.019) were both associated with a decrease in the gray matter volume of the left middle frontal gyrus (BA8). No significant decrease was found between white matter volume and BP measures in the whole brain and in frontal lobes.
BP-related decrease in left supplementary motor gray matter volume was associated with lower scores on part B of trail making test and ratio of Stroop test for 24-hour SBP (P=0.043 and P=0.013, respectively), for awake SBP (P=0.037 and P=0.018, respectively) and for MAP (P=0.048 and P=0.023, respectively). It was also associated with digit span score and ratio of Stroop test for 24-hour DBP (P=0.043 in both cases) and for sleep SBP (P=0.046 and P=0.027, respectively).
BP-related decrease in left superior frontal gyrus gray matter volume was also associated with lower score on part B of trail making test (P=0.006 for SBP, P=0.008 for awake SBP, P=0.043 for MAP). Finally, BP-related decrease in left middle frontal gyrus gray matter volume was associated with lower score on part B of trail making test (P=0.015 for sleep SBP and P=0.002 for sleep DPB) ( Table 4 ). No significant associations were found between BP-related decrease in gray matter volume and Mini-Mental State Examination score.
Discussion
This population-based study of elderly participants showed that high BP levels were associated with smaller gray matter volume in the supplementary motor area (BA6), regardless of the type of BP measures, whereas in the superior frontal gyrus (BA8), only high 24-hour and awake SBPs were associated with smaller gray matter volume. In addition, high-sleep SBP and DBP were significantly associated with smaller gray matter volume in the middle frontal gyrus (BA8). These BP-related decreases in gray matter volume in supplementary motor areas were significantly associated with decline in all ESDs performance, whereas BP-related decreases in gray matter volume in superior and middle frontal gyrus were only associated with a decline in mental shifting performance. All BP-related decreases in gray matter volume were shown on the left side. No significant BP-related decrease in white matter volume was found.
Previous studies of the effect of BP on brain tissue volume reduction have been conflicting, with some reports suggesting a significant association of high BP levels with brain volume reduction consistent with the current study and others showing no effect. [1] [2] [3] [4] [5] [6] [7] [8] [9] 11 These mixed findings may be attributable to a number of methodological factors including the cutoff value Table 2 †Comparison was based on χ 2 test. Table 3 . *Data were expressed in number of voxels.
. Prevalence of Leukoaraiosis Stratified by Class Following Fazekas Classification in Sample of Studied Participants Separated Into 2 Groups Based on the Use of Antihypertensive Drugs (n=183)
Localization of High Blood Pressure-Related Decreases in Gray Matter Volume According to 24-h Blood Pressure Measures Adjusted for Baseline Characteristics of Participants (n=183)
†Uncorrected P values for cluster were derived from linear regression model showing the association between decrease in volume of gray matter (dependent variable) and blood pressure measure adjusted on sex, duration of hypertension, use of antihypertensive drugs, body mass index, leukoaraiosis, and total brain matter volume; P significant (ie, <0.05) indicated in bold.
used to define hypertension, the most suitable BP assessment method, the technique used to assess brain volume reduction, and the control of confounders, such as age, sex, or total brain matter. In the current study, all these parameters were carefully controlled allowing observation of preferential localization of BP-related brain volume reduction in the frontal lobe and in particular in 2 Brodmann areas that were the supplementary motor areas (BA6) and the superior and middle frontal gyrus (BA8). The involvement of these areas has been reported in previous studies. [5] [6] [7] 23, 24 For instance, Gianaros et al 6 reported a similar high SBP-related decrease in gray matter in supplementary motor areas and the superior frontal gyrus. Furthermore, similar to Gianaros et al, 6 we found a preferential localization of high BP-related decrease in gray matter volume in the left hemisphere. We also found that the association between BP and gray matter volume depends on the type of BP measurement. Although the volume of the left supplementary motor area was affected by high BP, regardless of the type of BP measures, a BP-related decrease in gray matter volume of the left superior frontal gyrus was shown only for 24-hour and awake SBP.
The association of high BP with brain volume reduction in humans is supported by several animal models that have shown that BP-related brain volume reduction is caused by a decrease in cerebral blood flow, capillary abnormalities, and an alteration of the integrity of the blood-brain barrier. [24] [25] [26] [27] All these BP-related cerebral changes promote neuronal death and microglial and macrophage formation that may contribute to brain volume reduction. [24] [25] [26] [27] The specificity of BP-related focal volume reduction to the frontal cortex −=posterior]. In each section, white matter and cerebrospinal fluid are blackened. Profiled in color are brain regions in which higher blood pressure (red-yellow) is associated with lower gray matter volume. Color-scaled t values (legends at lower right on figure) were derived from a general linear model of voxelwise gray matter volume that included sex, the duration of hypertension, the use of antihypertensive drugs, body mass index, leukoaraiosis, and total brain matter volume as covariables. A P<0.05 threshold at uncorrected cluster level was used. observed in the current study may be related to ischemic effects that are supplied by the middle and anterior cerebral arteries. [25] [26] [27] Similarly, preferential BP-related left focal volume reduction suggests an asymmetry in the organization of the autonomic nervous system of the vessels with a greater sensitivity of the left hemisphere compared with the right one. Indeed, it was reported previously that SBP tended to be higher and less stable in patients with acute ischemic stroke localized in the left hemisphere compared with the right one. 28 Furthermore, Bagenas et al 29 have recently examined the evolution of SBP and heart rate (HR) over time after nigrostriatal lesions in normotensive and hypertensive rat strains. The authors showed that left brain lesions, but not right ones, produced an increase in SBP, which was particularly striking in hypertensive animals, suggesting that left injury may have a worse prognosis. The reason for the association between SBP and smaller supplementary motor area gray matter volume observed in the current study remains unclear. Indeed, some previous studies found an association between brain volume reduction and SBP but not DBP, whereas others found an association with DBP but not SBP. [1] [2] [3] [4] [5] [6] [7] [8] [9] 11 In our study, SBP and DBP have been associated with focal frontal volume reduction.
BP-related decreases in gray matter volume in the frontal lobe were associated with EF impairment. More specifically, we showed for the first time that BP-related decrease in supplementary motor area volume was independently associated with the decline in ESDs performance (eg, updating, shifting, and inhibition). This result is consistent with previous studies that showed executive impairment was related to supplementary motor area lesions. 6, 30 The involvement of the supplementary motor area in ESDs may be explained by the fact that this brain area receives afferent projections and sends efferent projections to several brain regions. 12, 13, 24, 25 Gray matter volume was calculated using only pixels that were significantly associated with the specific blood pressure measure being examined. SBP indicates systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure calculated from the formula: (SBP+[2×DBP])/3; BA, Brodmann area; β, coefficient of regression β corresponding with an increase or a decrease in cluster size; Digit span score, standardized total number of digits that a subject was able to absorb and recall in correct forward serial order after hearing them; TMTB score, time to connect the dots for 25 consecutive targets on a sheet of paper, part B (ie, alternated numbers and letters); Ratio of Stroop score, (no interference [color])/interference [color−word] with [color] corresponding with time to name color, and [color−word] corresponding with time to name the color of incongruent color words.
*Data shows separated models for each cognitive test. P significant (ie, <0.05) is indicated in bold.
The current study combined brain magnetic resonance imaging with the VBM method to characterize brain volume reduction. 12 Furthermore, a cluster-level P values approach was used, which was previously discouraged in VBM analyses because it is nonstationary (cluster P level depends on local smoothness, and VBM data are known to exhibit nonstationarity), but this approach is now acceptable in the latest versions of Statistical Parametric Mapping 8 v4290. The use of cluster-level analysis using P values that are uncorrected for multiple comparisons is a limitation of the current study. However, we had a preconceived hypothesis regarding the frontal area; therefore, it is possible to examine this region using uncorrected P statistics. The limitations of the method are described in the online-only Data Supplement.
In conclusion, high BP levels were significantly associated with focal frontal volume reduction involving left supplementary motor gray matter and superior and middle frontal gyrus gray matter, whereas no BP-related decrease in white matter volume was found in the studied sample of participants. Furthermore, the findings indicate that focal brain volume reduction is associated with a decline in ESDs performance. Further research is needed to corroborate these findings.
Perspectives
We suggest that the association of high BP with brain volume reduction provides new perspective about our understanding of BP-related cognitive decline leading to dementia. Because high BP could contribute to neurodegenerative lesions of dementia, such as Alzheimer disease, confirming and characterizing BP-related brain volume reduction shown in the current study may be helpful in understanding the process of cerebral volume reduction in neurodegenerative dementia.
